Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single versus tandem high-dose melphalan with autologous stem cell transplantation in multiple myeloma
DRKS00008864Phase 3Completed
- Sponsor
- Heidelberg University Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of melphalan in multiple myeloma (MM) (2 arms), sponsored by Heidelberg University Hospital. Started Jul 2015; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on DRKS00008864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00008864.